Phenotype of cells collected after immature dendritic cell preparation procedure in cancer patients
2011-12-31T00:01:48Z (GMT) by
<p><b>Copyright information:</b></p><p>Taken from "Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency"</p><p>Breast Cancer Research 2005;7(3):R326-R335.</p><p>Published online 25 Feb 2005</p><p>PMCID:PMC1143555.</p><p>Copyright © 2005 Gervais et al.; licensee BioMed Central Ltd</p> Peripheral blood mononuclear cells from healthy donors (= 11) or patients with colorectal cancer (= 7), renal cell carcinoma (= 10), or breast cancer (= 15) were depleted of lymphocytes (2-hour adherence step) and cultured for 7 days in the presence of granulocyte–macrophage colony-stimulating factor and IL-4. Data are expressed as the percentage of cells (with standard error) expressing the HLA-DRLinand HLA-DRLinphenotype. *< 0.01 versus healthy donors.